Correction: The PP2A regulator IER5L supports prostate cancer progression 

    Jana R Crespo et al.

    Cell Death Dis. 2025 Jul 22;16(1):545. doi: 10.1038/s41419-025-07802-x.

    Published on July 22, 2025

     

    NO ABSTRACT

    PMID:40695780 | DOI:10.1038/s41419-025-07802-x

     Read More

    Back to Publications
    Recent Publication
    Immune proteomic associations with indices of cortical development in 5-year-old children 
    Aaron Barron et al.J Anat. 2026 Sep 10:10.1111/joa.70225. doi: 10.1111/joa.70225. Online ahead of print.
    Recent Publication
    Functionalized neutrophil nanovesicles for targeted photodynamic immunotherapy and potentiation of checkpoint blockade in colorectal cancer 
    Yuan Zhong et al.Nanoscale. 2026 Sep 9. doi: 10.1039/d6nr01109h. Online ahead of print.
    Recent Publication
    A State-Gated Metallo-DNAzyme Framework Programs Tumor Stress Vulnerability Through Metabolic Licensing 
    Xiaodong Ma et al.Adv Sci (Weinh). 2026 Sep 8:e77520. doi: 10.1002/advs.77520. Online ahead of print.
    Recent Publication
    Integrating multi-omics technologies to decipher microbiome functions 
    Tim Van Den Bossche et al.Nat Commun. 2026 Sep 8;17(1):9600. doi: 10.1038/s41467-026-77539-4.
    Recent Publication
    Lifestyle, anthropometric factors and clinically significant prostate cancer diagnosis in men with suspected prostate cancer 
    Elja Heiskanen et al.Scand J Urol. 2026 Sep 8;61:223-229. doi: 10.2340/sju.v61.46749.

    More Publications

    Related Publication
    Reinstating Niche Failure in Diabetic Cranial Defects via Chronotaxic Signal-Amplifying Fluidic Biomimetic Hydrogel 
    Related Publication
    Single-cell RNA-seq analysis of longitudinal CD4+ T cell samples reveals cell-type-specific changes during early stages of type 1 diabetes 
    Related Publication
    Joint modeling of longitudinal and time-to-event data for dynamic disease risk prediction using proteomics